Cargando…
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy
BACKGROUND: Cardiomyopathy is a common side effect of doxorubicin (DOX) chemotherapy. Despite intensive research efforts in the field, there is still no evidence available for routine cardioprotective prophylaxis to prevent cardiotoxicity in the majority of oncological patients at low risk of cardio...
Autores principales: | Lódi, Mária, Bánhegyi, Viktor, Bódi, Beáta, Gyöngyösi, Alexandra, Kovács, Árpád, Árokszállási, Anita, Hamdani, Nazha, Fagyas, Miklós, Édes, István, Csanádi, Zoltán, Czuriga, István, Kisvárday, Zoltán, Lekli, István, Bai, Péter, Tóth, Attila, Papp, Zoltán, Czuriga, Dániel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725221/ https://www.ncbi.nlm.nih.gov/pubmed/33298102 http://dx.doi.org/10.1186/s12967-020-02564-w |
Ejemplares similares
-
Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy
por: Lódi, Mária, et al.
Publicado: (2019) -
Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart
por: Bánhegyi, Viktor, et al.
Publicado: (2021) -
Cell-to-cell variability in troponin I phosphorylation in a porcine model of pacing-induced heart failure
por: Czuriga, Dániel, et al.
Publicado: (2012) -
Rapamycin treatment increases survival, autophagy biomarkers and expression of the anti‐aging klotho protein in elderly mice
por: Szőke, Kitti, et al.
Publicado: (2023) -
Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
por: Csató, Gábor, et al.
Publicado: (2022)